Diabetus TBL Flashcards

1
Q

insulin MOA

A

activates the TK insulin receptors on liver, skeltal muscle and adipose tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

effects of insulin on liver

A

increases glucose storage by inserting additional GLUT2 receptors and decreases protein metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

effects of insulin on skeletal muscle

A

stimulates glycogen synthesis and protein syntheis by activating glut4 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

effects of insulin on adipose tissue

A

facilities trigliceride storage by activating lipoprotein lipase inceraseing glucose uptake into cells via glut4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

rapid acting insulin

A

lispro aspar glulisine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

use of rapid acting insulin

A

before a meal, continupus subQ infusion, emergancy treatment for ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

intermediate-acting insulin

A

hagedom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

long acting insulin

A

glargine and detemir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

use of long actine insulin

A

control basal glucose levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SE of insulin

A

hypoglycemia

rare allergic reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

population with risk of insulin hypoglycemia

A

old and kidney pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

metformin

A

inhibits gluconeogenesis, stimulating glucose uptake and glycolosis on peripheral tissuesm slowing glucose uptake in GI and reducing plasma glucgon levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

effects of metformin

A

reduces postprandial and fasting glucose levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

use of metformin

A

first line in Type II DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

restores infertility with PCOD and insulin resistance

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

used to reduce risk of DM in high risk pts

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SE of metformin

A

GI distress

n/v leading to acidocis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

tolbutamide

A

sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

cholorpropamide

A

sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

glyburide

A

sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

glipizide

A

sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

glimepiride

A

sulfonylureas

23
Q

MOA of sulfonylureas

A

closes K channels in beta cell membranes resulting in depolarizing cells

24
Q

effect of sulfonylureas

A

release of endogenous insulin by beta cells

25
sulfonylureas will not work on
Juvinle diabetes
26
SE of sulfonylureas
hypoglycemia allergic rxn weight gain
27
rosiglitazone
thiazoledindiones
28
pioglizatone
thiazoledindiones
29
thiazoledindiones MOA
activates PPAR-y which regulates genes involved in carbohydrate and lipd metabolism
30
thiazoledindiones effect
increase insulin sensitivity in muscle and adipose and inhibits hepatic gluconeogenesis
31
thiazoledindiones use
reduce fasting and postprandial hyperglycemia
32
SE of thiazoledindiones
fluid retension anemia Edema leading to increased risk of CHF bone fractures in women
33
drug that has MI risk
rosiglitizone
34
drug class with liver risk
thiazoledindiones
35
inhbits DPP-4 degrading glucagon like peptide and other incretins
sitagliptin
36
use of sitagliptin
DM2
37
SE of sitagliptin
headachem nasopharyngitis URTI
38
can mask sx of hypoglycemis
beta-blockers
39
diuretics that can impair release of insulin and tissue utilization of glucose
thiazide
40
pathogenisis of DM1
lack of insulin secretion due to loss of beta cells -auto-immune destruction of Beta cells by T-cells
41
pathogenisis of DMII
peripheral resistance to insulin and inadequate compensatory response by beta cells
42
mutations in DMI
CTLA4 and PTPN22
43
diseases that can trigger diabetes
mumps, rubella, coxsackie
44
inhibtors of insulin signalling
TGs
45
replaces islets of langerhauns in long term DMII
amyloid
46
DX criteria of DM
HbA1C > 6.4 OR fasting glucose >125 OR >200 mg/dl in glucose tolerance test OR SX of hyperglycemia/hyperglycemic crisis and random glucose over 200
47
goals of insulin therapy
get A1C at or below 7% possibly higher if pt is sick possibly lower if pt is young and healthy
48
complications of DM
``` pancreatic changes CVD stroke renal failure gangrene hyalline arteriosclerosis Diabetic neuropathy visual impairments CNS damage infection ```
49
BP goals for diabetiics
better than 140/80
50
pharm therapy for HTN in diabetes
ACEi or ARB
51
preggers BP goals in diabetics
110-129/65-79
52
contraindicated in preggers
ARBs and ACE inhibitors, statins
53
fats goals
TG 40